Literature DB >> 31855245

Homozygous GRN mutations: new phenotypes and new insights into pathological and molecular mechanisms.

Vincent Huin1, Mathieu Barbier1, Armand Bottani2, Johannes Alexander Lobrinus3, Fabienne Clot4, Foudil Lamari5, Laureen Chat4, Benoît Rucheton5, Frédérique Fluchère6, Stéphane Auvin7, Peter Myers8, Antoinette Gelot9, Agnès Camuzat1, Catherine Caillaud10, Ludmila Jornéa1, Sylvie Forlani1, Dario Saracino1, Charles Duyckaerts11, Alexis Brice1,12, Alexandra Durr1,12, Isabelle Le Ber1,13.   

Abstract

Homozygous mutations in the progranulin gene (GRN) are associated with neuronal ceroid lipofuscinosis 11 (CLN11), a rare lysosomal-storage disorder characterized by cerebellar ataxia, seizures, retinitis pigmentosa, and cognitive disorders, usually beginning between 13 and 25 years of age. This is a rare condition, previously reported in only four families. In contrast, heterozygous GRN mutations are a major cause of frontotemporal dementia associated with neuronal cytoplasmic TDP-43 inclusions. We identified homozygous GRN mutations in six new patients. The phenotypic spectrum is much broader than previously reported, with two remarkably distinct presentations, depending on the age of onset. A childhood/juvenile form is characterized by classical CLN11 symptoms at an early age at onset. Unexpectedly, other homozygous patients presented a distinct delayed phenotype of frontotemporal dementia and parkinsonism after 50 years; none had epilepsy or cerebellar ataxia. Another major finding of this study is that all GRN mutations may not have the same impact on progranulin protein synthesis. A hypomorphic effect of some mutations is supported by the presence of residual levels of plasma progranulin and low levels of normal transcript detected in one case with a homozygous splice-site mutation and late onset frontotemporal dementia. This is a new critical finding that must be considered in therapeutic trials based on replacement strategies. The first neuropathological study in a homozygous carrier provides new insights into the pathological mechanisms of the disease. Hallmarks of neuronal ceroid lipofuscinosis were present. The absence of TDP-43 cytoplasmic inclusions markedly differs from observations of heterozygous mutations, suggesting a pathological shift between lysosomal and TDP-43 pathologies depending on the mono or bi-allelic status. An intriguing observation was the loss of normal TDP-43 staining in the nucleus of some neurons, which could be the first stage of the TDP-43 pathological process preceding the formation of typical cytoplasmic inclusions. Finally, this study has important implications for genetic counselling and molecular diagnosis. Semi-dominant inheritance of GRN mutations implies that specific genetic counselling should be delivered to children and parents of CLN11 patients, as they are heterozygous carriers with a high risk of developing dementia. More broadly, this study illustrates the fact that genetic variants can lead to different phenotypes according to their mono- or bi-allelic state, which is a challenge for genetic diagnosis.
© The Author(s) (2019). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  TDP-43; cerebellar ataxia; frontotemporal dementia/frontotemporal lobar degeneration; neuronal ceroid lipofuscinosis; progranulin/GRN

Mesh:

Substances:

Year:  2020        PMID: 31855245     DOI: 10.1093/brain/awz377

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  11 in total

1.  Progranulin Insufficiency Affects Lysosomal Homeostasis in Retinal Pigment Epithelium.

Authors:  Kei Takahashi; Shinsuke Nakamura; Masamitsu Shimazawa; Hideaki Hara
Journal:  In Vivo       Date:  2022 Mar-Apr       Impact factor: 2.155

2.  Lysosomal Diseases and Neuropsychiatry: Opportunities to Rebalance the Mind.

Authors:  Timothy M Cox
Journal:  Front Mol Biosci       Date:  2020-08-26

Review 3.  Neuronal Ceroid Lipofuscinosis: Potential for Targeted Therapy.

Authors:  Nicola Specchio; Alessandro Ferretti; Marina Trivisano; Nicola Pietrafusa; Chiara Pepi; Costanza Calabrese; Susanna Livadiotti; Alessandra Simonetti; Paolo Rossi; Paolo Curatolo; Federico Vigevano
Journal:  Drugs       Date:  2021-01       Impact factor: 9.546

4.  Lysosomal Dysfunction and Other Pathomechanisms in FTLD: Evidence from Progranulin Genetics and Biology.

Authors:  Xiaolai Zhou; Thomas Kukar; Rosa Rademakers
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 5.  Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis.

Authors:  Jessica Root; Paola Merino; Austin Nuckols; Michelle Johnson; Thomas Kukar
Journal:  Neurobiol Dis       Date:  2021-03-31       Impact factor: 7.046

6.  Neuropathological and behavioral characterization of aged Grn R493X progranulin-deficient frontotemporal dementia knockin mice.

Authors:  Jonathan Frew; Haakon Berge Nygaard
Journal:  Acta Neuropathol Commun       Date:  2021-04-01       Impact factor: 7.801

7.  Loss of Tmem106b exacerbates FTLD pathologies and causes motor deficits in progranulin-deficient mice.

Authors:  Xiaolai Zhou; Mieu Brooks; Peizhou Jiang; Shunsuke Koga; Aamir R Zuberi; Matthew C Baker; Tammee M Parsons; Monica Castanedes-Casey; Virginia Phillips; Ariston L Librero; Aishe Kurti; John D Fryer; Guojun Bu; Cathleen Lutz; Dennis W Dickson; Rosa Rademakers
Journal:  EMBO Rep       Date:  2020-08-05       Impact factor: 8.807

8.  Neuronal VCP loss of function recapitulates FTLD-TDP pathology.

Authors:  Abubakar Wani; Jiang Zhu; Jason D Ulrich; Abdallah Eteleeb; Andrew D Sauerbeck; Sydney J Reitz; Khalid Arhzaouy; Chiseko Ikenaga; Carla M Yuede; Sara K Pittman; Feng Wang; Shan Li; Bruno A Benitez; Carlos Cruchaga; Terrance T Kummer; Oscar Harari; Tsui-Fen Chou; Rolf Schröder; Christoph S Clemen; Conrad C Weihl
Journal:  Cell Rep       Date:  2021-07-20       Impact factor: 9.423

9.  Network analysis of the progranulin-deficient mouse brain proteome reveals pathogenic mechanisms shared in human frontotemporal dementia caused by GRN mutations.

Authors:  Meixiang Huang; Erica Modeste; Eric Dammer; Paola Merino; Georgia Taylor; Duc M Duong; Qiudong Deng; Christopher J Holler; Marla Gearing; Dennis Dickson; Nicholas T Seyfried; Thomas Kukar
Journal:  Acta Neuropathol Commun       Date:  2020-10-07       Impact factor: 7.578

10.  Elevated levels of extracellular vesicles in progranulin-deficient mice and FTD-GRN Patients.

Authors:  Andrew E Arrant; Skylar E Davis; Rachael M Vollmer; Charles F Murchison; James A Mobley; Alissa L Nana; Salvatore Spina; Lea T Grinberg; Anna M Karydas; Bruce L Miller; William W Seeley; Erik D Roberson
Journal:  Ann Clin Transl Neurol       Date:  2020-11-16       Impact factor: 5.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.